Literature DB >> 19343091

Spontaneous improvement of rod system function in a patient with melanoma-associated retinopathy.

Linda S Kim1, Kenneth R Alexander, Gerald A Fishman.   

Abstract

PURPOSE: To report spontaneous improvement of rod visual function in a patient with melanoma-associated retinopathy (MAR).
METHODS: Electroretinography (ERG), and dark-adapted psychophysical thresholds were performed on a male patient with the MAR syndrome, during four visits over a period of almost 7 years.
RESULTS: There was a spontaneous, subjective improvement in night vision and a decrease in the severity of photopsias of the patient's left eye between the initial and most recent visits. Both the dark-adapted rod-isolated and maximal-flash b-wave ERG amplitude also improved his initial visit to the most recent visit. By comparison, the light-adapted brief-flash and flicker ERG amplitudes were initially within the range of normal in the left eye but showed a subsequent reduction in amplitude. The ERG response of the right eye was only measured at the most recent visit, but gave a dark-adapted response that was similar to that of the left eye on the initial visit, and a light-adapted response that was similar to that of the left eye on the most recent visit. Rod sensitivity was substantially better in the left eye than in the right eye by psychophysical testing, although the right eye did show a noticeable level of improvement in rod thresholds between the initial and most recent visits.
CONCLUSIONS: These findings document the potential for spontaneous improvement in electrophysiological and psychophysical rod function, as well as in subjective symptoms, in patients with the MAR syndrome.

Entities:  

Year:  2008        PMID: 19343091      PMCID: PMC2572861          DOI: 10.1097/icb.0b013e318033a41c

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  10 in total

1.  Nature of the cone ON-pathway dysfunction in melanoma-associated retinopathy.

Authors:  Kenneth R Alexander; Claire S Barnes; Gerald A Fishman; Ann H Milam
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

2.  Rod and cone dysfunction in carriers of X-linked retinitis pigmentosa.

Authors:  N S Peachey; G A Fishman; D J Derlacki; K R Alexander
Journal:  Ophthalmology       Date:  1988-05       Impact factor: 12.079

3.  Congenital stationary night blindness with negative electroretinogram. A new classification.

Authors:  Y Miyake; K Yagasaki; M Horiguchi; Y Kawase; T Kanda
Journal:  Arch Ophthalmol       Date:  1986-07

4.  I. Electroretinographic changes in normal eyes during administration of prednisone.

Authors:  T J Zimmerman; W W Dawson; C R Fitzgerald
Journal:  Ann Ophthalmol       Date:  1973-07

Review 5.  Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.

Authors:  J L Keltner; C E Thirkill; P T Yip
Journal:  J Neuroophthalmol       Date:  2001-09       Impact factor: 3.042

6.  Corticosteroid treatment for melanoma-associated retinopathy: effect on visual acuity and electrophysiologic findings.

Authors:  Caroline Jacobzone; Catherine Cochard-Marianowski; Ingrid Kupfer; Samia Bettembourg; Yves Dordain; Laurent Misery; Beatrice Cochener; Bruno Sassolas
Journal:  Arch Dermatol       Date:  2004-10

7.  'On' response defect in paraneoplastic night blindness with cutaneous malignant melanoma.

Authors:  K R Alexander; G A Fishman; N S Peachey; A L Marchese; M O Tso
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-03       Impact factor: 4.799

8.  Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy.

Authors:  A H Milam; J C Saari; S G Jacobson; W P Lubinski; L G Feun; K R Alexander
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-01       Impact factor: 4.799

9.  Contrast-processing deficits in melanoma-associated retinopathy.

Authors:  Kenneth R Alexander; Claire S Barnes; Gerald A Fishman; Joel Pokorny; Vivianne C Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-01       Impact factor: 4.799

10.  Paraneoplastic night blindness with malignant melanoma.

Authors:  E L Berson; S Lessell
Journal:  Am J Ophthalmol       Date:  1988-09-15       Impact factor: 5.258

  10 in total
  4 in total

1.  Case of paraneoplastic retinopathy with retinal ON-bipolar cell dysfunction and subsequent resolution of ERGs.

Authors:  Shinji Ueno; Ayami Nakanishi; Kayo Nishi; Shiro Suzuki; Hiroko Terasaki
Journal:  Doc Ophthalmol       Date:  2014-11-13       Impact factor: 2.379

2.  TRP channel gene expression in the mouse retina.

Authors:  Jared C Gilliam; Theodore G Wensel
Journal:  Vision Res       Date:  2011-10-20       Impact factor: 1.886

3.  Delayed presentation of melanoma-associated retinopathy and subsequent resolution with cytoreduction surgery.

Authors:  Richard E Stead; Maryke A Fox; Emily Staples; Chea S Lim
Journal:  Doc Ophthalmol       Date:  2013-06-22       Impact factor: 2.379

4.  Choroidal atrophy in a patient with paraneoplastic retinopathy and anti-TRPM1 antibody.

Authors:  Shinji Ueno; Yasuki Ito; Ruka Maruko; Mineo Kondo; Hiroko Terasaki
Journal:  Clin Ophthalmol       Date:  2014-02-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.